Cel-Sci
CVM
#10616
Rank
C$28.41 M
Marketcap
C$1.63
Share price
-4.92%
Change (1 day)
-87.52%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of March 2026 : C$24.82 Million

According to Cel-Sci 's latest financial reports the company's total assets are C$24.82 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-09-30C$39.2 M7.37%
2024-09-30C$36.51 M-12%
2023-09-30C$41.48 M-40.4%
2022-09-30C$69.61 M-27.66%
2021-09-30C$96.23 M78.42%
2020-09-30C$53.93 M47.45%
2019-09-30C$36.57 M-3.72%
2018-09-30C$37.99 M33.6%
2017-09-30C$28.43 M-13.19%
2016-09-30C$32.75 M-13.85%
2015-09-30C$38.02 M76.46%
2014-09-30C$21.54 M92.59%
2013-09-30C$11.18 M-29.24%
2012-09-30C$15.81 M-18.09%
2011-09-30C$19.3 M-50.46%
2010-09-30C$38.97 M-21.92%
2009-09-30C$49.91 M219.71%
2008-09-30C$15.61 M-24.08%
2007-09-30C$20.56 M90.75%
2006-09-30C$10.78 M197.6%
2005-09-30C$3.62 M-47.89%
2004-09-30C$6.95 M77.29%
2003-09-30C$3.92 M-34.12%
2002-09-30C$5.95 M-16.41%
2001-09-30C$7.12 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$281.59 B 1,134,426.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$129.66 B 522,306.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$1.03 B 4,061.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C$41.61 M 67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$56.12 B 226,021.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
C$0.65 B 2,526.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.85 B 7,356.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$14.77 M-40.46%๐Ÿ‡บ๐Ÿ‡ธ USA